Brexit: Companies Must ‘Act Now’ To Avoid Drug Supply Disruptions In 2021

First Ferry Tickets About To Be Released

In its latest letter to medicines and medical product companies, the UK's Department of Health and Social Care says the biggest potential cause of disruption to supplies could be failure to prepare for border controls implemented by the EU member states after the end of the Brexit transition period.

Woman's hand holding a ferry ticket on white background close-up
Companies may want to book ferry tickets before the boat sails in January • Source: Shutterstock

With the prospect of a future UK/EU trade deal hanging by a thread, the UK government has urged suppliers of medicines and medical products to “act now” to prepare for the new customs and border controls that will be imposed on 1 January 2021.

In a 17 November letter to suppliers, Steve Oldfield, chief commercial officer at the Department of Health and Social Care,...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography